Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:COCH NASDAQ:ECOR NASDAQ:MODD NASDAQ:PAVM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$0.95+2.0%$1.22$0.74▼$3.11$22.60M2.09959,015 shs2.16 million shsECORelectroCore$5.26+2.1%$5.24$4.16▼$19.49$42.08M0.34118,276 shs61,081 shsMODDModular Medical$0.67+0.1%$0.72$0.63▼$2.37$36.89M0.17234,338 shs80,908 shsPAVMPAVmed$0.49+2.9%$0.45$0.30▼$1.26$10.72M1.07200,265 shs365,571 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical-41.50%+20.25%-29.00%-35.41%-68.26%ECORelectroCore+4.04%+4.25%+4.67%-31.79%-34.56%MODDModular Medical-0.51%-4.23%-7.44%-10.91%-68.71%PAVMPAVmed-2.18%+7.95%+10.47%-20.83%-60.42%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$0.95+2.0%$1.22$0.74▼$3.11$22.60M2.09959,015 shs2.16 million shsECORelectroCore$5.26+2.1%$5.24$4.16▼$19.49$42.08M0.34118,276 shs61,081 shsMODDModular Medical$0.67+0.1%$0.72$0.63▼$2.37$36.89M0.17234,338 shs80,908 shsPAVMPAVmed$0.49+2.9%$0.45$0.30▼$1.26$10.72M1.07200,265 shs365,571 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical-41.50%+20.25%-29.00%-35.41%-68.26%ECORelectroCore+4.04%+4.25%+4.67%-31.79%-34.56%MODDModular Medical-0.51%-4.23%-7.44%-10.91%-68.71%PAVMPAVmed-2.18%+7.95%+10.47%-20.83%-60.42%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOCHEnvoy Medical 2.33Hold$9.25874.61% UpsideECORelectroCore 2.33Hold$25.50384.79% UpsideMODDModular Medical 1.00SellN/AN/APAVMPAVmed 2.00Hold$20.003,989.98% UpsideCurrent Analyst Ratings BreakdownLatest PAVM, COCH, MODD, and ECOR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025COCHEnvoy MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025ECORelectroCoreWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025PAVMPAVmedWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/6/2025PAVMPAVmedAscendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$19.00 ➝ $20.009/27/2025COCHEnvoy MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025ECORelectroCoreWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025MODDModular MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025PAVMPAVmedWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)(Data available from 10/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOCHEnvoy Medical$220K102.72N/AN/A($0.88) per share-1.08ECORelectroCore$25.18M1.67N/AN/A$1.13 per share4.65MODDModular MedicalN/AN/AN/AN/A$0.42 per shareN/APAVMPAVmed$2.99M3.59N/AN/A($0.92) per share-0.53Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOCHEnvoy Medical-$20.80M-$1.43N/AN/AN/A-10,961.26%N/A-236.14%11/13/2025 (Estimated)ECORelectroCore-$11.89M-$1.62N/AN/AN/A-47.84%-221.93%-69.17%11/12/2025 (Estimated)MODDModular Medical-$18.82M-$0.51N/A∞N/AN/A-185.60%-158.95%11/13/2025 (Estimated)PAVMPAVmed$39.79M$1.160.42N/AN/A7,144.80%N/A-20.96%11/12/2025 (Estimated)Latest PAVM, COCH, MODD, and ECOR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q1 2026MODDModular Medical-$0.10-$0.12-$0.02-$0.12$0.20 millionN/A8/6/2025Q2 2025ECORelectroCore-$0.32-$0.35-$0.03-$0.44$7.24 million$7.38 million7/31/2025Q2 2025COCHEnvoy Medical-$0.29-$0.32-$0.03-$0.32$0.07 million$0.08 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCOCHEnvoy MedicalN/AN/AN/AN/AN/AECORelectroCoreN/AN/AN/AN/AN/AMODDModular MedicalN/AN/AN/AN/AN/APAVMPAVmedN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOCHEnvoy MedicalN/A0.940.74ECORelectroCoreN/A1.100.95MODDModular MedicalN/A4.044.04PAVMPAVmedN/A0.520.52Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOCHEnvoy Medical8.59%ECORelectroCore26.74%MODDModular Medical27.47%PAVMPAVmed19.93%Insider OwnershipCompanyInsider OwnershipCOCHEnvoy Medical58.90%ECORelectroCore13.80%MODDModular Medical20.46%PAVMPAVmed7.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOCHEnvoy Medical3423.81 million9.79 millionNot OptionableECORelectroCore508.00 million6.89 millionNot OptionableMODDModular Medical2055.28 million43.97 millionNot OptionablePAVMPAVmed9021.93 million20.33 millionOptionablePAVM, COCH, MODD, and ECOR HeadlinesRecent News About These CompaniesPAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership AgreementOctober 7 at 8:01 AM | prnewswire.comAscendiant Capital Maintains PAVmed (PAVM) Buy RecommendationOctober 7 at 6:22 AM | msn.comPAVmed (NASDAQ:PAVM) Stock Price Expected to Rise, Ascendiant Capital Markets Analyst SaysOctober 7 at 2:04 AM | americanbankingnews.comLucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government AffairsSeptember 16, 2025 | prnewswire.comMedtech company to license Duke’s esophageal precancer detection probeSeptember 15, 2025 | beckersasc.comBMedtech company to license Duke’s esophageal precancer detection probeSeptember 15, 2025 | beckersasc.comBLucid Diagnostics Shares Fall After Pricing of Public Stock OfferingSeptember 11, 2025 | marketwatch.comPAVmed’s Lucid Diagnostics Completes Public Stock OfferingSeptember 11, 2025 | tipranks.comLucid Diagnostics Announces Closing of Public Offering of Common StockSeptember 11, 2025 | prnewswire.comLucid Diagnostics Announces Pricing of Public Offering of Common StockSeptember 10, 2025 | prnewswire.comLucid Diagnostics Announces Proposed Public Offering of Common StockSeptember 9, 2025 | prnewswire.comLucid Diagnostics to Host Investor Call on Monday, September 8, 2025September 5, 2025 | prnewswire.comPAVmed enters letter of intent with Duke University to license groundbreaking endoscopic esophageal imaging technologyAugust 28, 2025 | pharmabiz.comPPAVmed plans to license Duke’s oesophageal imaging technologyAugust 28, 2025 | finance.yahoo.comLucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025August 27, 2025 | prnewswire.comPAVmed to license esophageal imaging technology from Duke TechnologyAugust 26, 2025 | msn.comPavmed licenses endoscopic esophageal imaging tech out of DukeAugust 26, 2025 | massdevice.comPAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging TechnologyAugust 26, 2025 | prnewswire.comPAVmed Revenue Jumps 513% in Q2August 14, 2025 | aol.comALucid Diagnostics Reports Q2 2025 Financial ResultsAugust 14, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePAVM, COCH, MODD, and ECOR Company DescriptionsEnvoy Medical NASDAQ:COCH$0.95 +0.02 (+2.04%) Closing price 04:00 PM EasternExtended Trading$1.01 +0.07 (+6.94%) As of 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.electroCore NASDAQ:ECOR$5.26 +0.11 (+2.14%) Closing price 04:00 PM EasternExtended Trading$5.24 -0.02 (-0.38%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Modular Medical NASDAQ:MODD$0.67 +0.00 (+0.14%) Closing price 04:00 PM EasternExtended Trading$0.67 +0.00 (+0.40%) As of 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.PAVmed NASDAQ:PAVM$0.49 +0.01 (+2.95%) Closing price 04:00 PM EasternExtended Trading$0.49 +0.00 (+0.61%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AI Meets Nuclear: Palantir’s Role in Energy Expansion Buy the Dip? Zillow’s Profit Comeback Meets Market Pressure Adobe Launches Premiere Pro on iPhone, Upside Ahead? Rocket Lab: A Space Giant Hitting New Highs—Time to Chase? After AI Hyperscaler Deal, Is Aehr Test Systems Stock on Sale? Why Archer Aviation Stock Is Soaring—And What Comes Next Lithium Americas: Why This 31% Rally Is More Than Just a Headline Energy Transfer's New Growth Engine Ignites Investor Interest Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
